VTVT - vTv Therapeutics Inc. Analyst Forecast Prices

vTv Therapeutics Inc. (VTVT) operates based on an internal development cycle for oral type 1 diabetes treatments, where scientific breakthroughs serve as the primary driver of valuation growth. This historical price chart on GURU.Markets, with a value of 59.85, demonstrates a dependence on test results and partnerships with research centers. Currently, the company is burning capital on R&D without commercial revenue, which eliminates cash flow predictability.

vTv Therapeutics Inc. - VTVT Consensus Target (period 07/04/2022 - 11/15/2026)

Analytical breakdowns for vTv Therapeutics, Inc. (VTVT)

- current price and projected stock value:

Price Chart vTv Therapeutics Inc|VTVT - Consensus Target

- market capitalization statistics:

Market Value vTv Therapeutics Inc.|VTVT - Real Price to Acquire Entire Company

- book capitalization information:

Net Assets per Single Share vTv Therapeutics|VTVT - Company Net Assets|Market Cap to Book Value Multiple vtvtherapeutics.com|VTVT - Aggregate Company Assets

- business debt structure and liquidity details:

Aggregate Debt to Equity vTv Therapeutics Inc.|VTVT - Long-Term Debt to Capital|Ratio of Short-Term Indebtedness to Capital vTv Therapeutics|VTVT - Company Aggregate Debts|Debts to Book Capitalization vTv Therapeutics|VTVT - Company Long-Term Debt|Company Short-Term Loans and Borrowings vTv Therapeutics|Quick Liquidity Indicator vtvtherapeutics.com

- financial results and valuation multiples details:

VTVT - Net Profit|Projected Future Earnings vTv Therapeutics Inc.|VTVT - Price to Earnings Ratio|Future Price to Earnings Multiple vTv Therapeutics, Inc.|VTVT - Price/Earnings to Growth Ratio|Enterprise Value to EBITDA Ratio vTv Therapeutics, Inc.|VTVT - Operating profit EBITDA|Net earnings per one share for the last twelve months vTv Therapeutics|VTVT - Net earnings per share for the last 12 months|Year-over-year earnings per share growth rate for the last twelve months vtvtherapeutics.com|VTVT - Earnings growth in current year|Earnings growth forecast for next year vTv Therapeutics Inc.

- sales revenue and business income indicators:

VTVT - Revenue and Sales Volume|Company Projected Revenue vTv Therapeutics, Inc.|VTVT - Price-to-Revenue Ratio|Market Cap to Future Revenue Ratio vTv Therapeutics

General company analysis:VTVT vTv Therapeutics Inc.

Flagship merchandise of vTv Therapeutics

Strategic alliances of vTv Therapeutics Inc. (VTVT) in the development of type 1 diabetes drugs directly influence the dynamics of target valuations within the investment community. This indicator aggregates average analyst forecasts, identifying liquidity anomalies and the risk of the asset becoming overbought during periods of extreme volatility, which allows investors to synchronize share price revisions with the fundamental successes of the company's clinical trials.

Competitors of vTv Therapeutics Inc.